As of Nov 25
| -0.39 / -6.54%|
The 6 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 16.72, with a high estimate of 50.59 and a low estimate of 4.71. The median estimate represents a +200.15% increase from the last price of 5.57.
The current consensus among 6 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.